Octant Bio (Series B)
Funding Details
- Awarder
- Gaingels
- Date Award
- May 24, 2024
- Vertical
- Healthcare and Biotech
- Funding URL
- View Funding Page
- Valuation
- $225,000,000
Company Info
- Founders
- Sri Kosuri
- Company Description
- Developer of synthetic technology used to improve health and treat disease Octant Bio is a developer of synthetic technology used to improve health and treat disease.
- Market
- Healthcare & Wellness
- Coinvestors
- Fifty Years,Bristol-Myers Squibb,Catalio Capital Management,Andreessen Horowitz